|
FR640907A
(fr)
|
1927-06-25 |
1928-07-24 |
|
Limitateur de débit automatique
|
|
US2168437A
(en)
|
1935-04-10 |
1939-08-08 |
Kenneth O Buercklin |
Injection device
|
|
US2110208A
(en)
|
1937-02-12 |
1938-03-08 |
U S Standard Products Company |
Antigen preparations
|
|
US2531724A
(en)
|
1948-09-20 |
1950-11-28 |
Edmund D Cevasco |
Infant bath mat
|
|
US3025991A
(en)
|
1960-05-23 |
1962-03-20 |
Carron Products Co |
Bottle stopper
|
|
NL280825A
(2)
|
1962-07-11 |
|
|
|
|
GB1049104A
(en)
|
1963-05-11 |
1966-11-23 |
Prodotti Antibiotici Spa |
Pharmaceutical compositions for oral or parenteral administration comprising tetracycline antibiotics
|
|
US3122162A
(en)
|
1963-06-20 |
1964-02-25 |
Asa D Sands |
Flow control device
|
|
BE744162A
(fr)
|
1969-01-16 |
1970-06-15 |
Fuji Photo Film Co Ltd |
Procede d'encapsulage
|
|
US3632768A
(en)
|
1969-10-02 |
1972-01-04 |
Upjohn Co |
Therapeutic composition and method for treating infections with actinospectacin
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
DE2010115A1
(de)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
|
US3625214A
(en)
|
1970-05-18 |
1971-12-07 |
Alza Corp |
Drug-delivery device
|
|
US3732865A
(en)
|
1971-01-13 |
1973-05-15 |
Alza Corp |
Osmotic dispenser
|
|
US4034756A
(en)
|
1971-01-13 |
1977-07-12 |
Alza Corporation |
Osmotically driven fluid dispenser
|
|
US3995631A
(en)
|
1971-01-13 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
|
|
US4211771A
(en)
|
1971-06-01 |
1980-07-08 |
Robins Ronald K |
Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
|
|
JPS523342B2
(2)
|
1972-01-26 |
1977-01-27 |
|
|
|
BE795516A
(fr)
|
1972-02-17 |
1973-08-16 |
Ciba Geigy |
Preparations de peptides huileuses et injectables et procede pour leur preparation
|
|
US3797492A
(en)
|
1972-12-27 |
1974-03-19 |
Alza Corp |
Device for dispensing product with directional guidance member
|
|
US3995632A
(en)
|
1973-05-04 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser
|
|
GB1413186A
(en)
|
1973-06-27 |
1975-11-12 |
Toyo Jozo Kk |
Process for encapsulation of medicaments
|
|
DE2528516A1
(de)
|
1974-07-05 |
1976-01-22 |
Sandoz Ag |
Neue galenische zubereitung
|
|
JPS523653A
(en)
|
1975-06-27 |
1977-01-12 |
Fuji Photo Film Co Ltd |
Process for producing fine polymer particles
|
|
US3987790A
(en)
|
1975-10-01 |
1976-10-26 |
Alza Corporation |
Osmotically driven fluid dispenser
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4078060A
(en)
|
1976-05-10 |
1978-03-07 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response
|
|
US4203439A
(en)
|
1976-11-22 |
1980-05-20 |
Alza Corporation |
Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
|
|
US4111203A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
|
US4111202A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for the controlled and delivery of agent over time
|
|
US4111201A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility
|
|
USD258837S
(en)
|
1977-10-17 |
1981-04-07 |
Gambro Dialysatoren Gmbh And Co. Kg |
Dialyzer cartridge
|
|
USD259458S
(en)
|
1978-06-09 |
1981-06-09 |
Fuller Charles R |
Support pad for an infant
|
|
US4243030A
(en)
|
1978-08-18 |
1981-01-06 |
Massachusetts Institute Of Technology |
Implantable programmed microinfusion apparatus
|
|
US4305927A
(en)
|
1979-02-05 |
1981-12-15 |
Alza Corporation |
Method for the management of intraocular pressure
|
|
US4373527B1
(en)
|
1979-04-27 |
1995-06-27 |
Univ Johns Hopkins |
Implantable programmable medication infusion system
|
|
US4310516A
(en)
|
1980-02-01 |
1982-01-12 |
Block Drug Company Inc. |
Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
|
|
US4384975A
(en)
|
1980-06-13 |
1983-05-24 |
Sandoz, Inc. |
Process for preparation of microspheres
|
|
AU546785B2
(en)
|
1980-07-23 |
1985-09-19 |
Commonwealth Of Australia, The |
Open-loop controlled infusion of diabetics
|
|
US4350271A
(en)
|
1980-08-22 |
1982-09-21 |
Alza Corporation |
Water absorbing fluid dispenser
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
US4376118A
(en)
|
1980-10-06 |
1983-03-08 |
Miles Laboratories, Inc. |
Stable nonaqueous solution of tetracycline salt
|
|
PH19942A
(en)
|
1980-11-18 |
1986-08-14 |
Sintex Inc |
Microencapsulation of water soluble polypeptides
|
|
US4340054A
(en)
|
1980-12-29 |
1982-07-20 |
Alza Corporation |
Dispenser for delivering fluids and solids
|
|
US4444498A
(en)
|
1981-02-27 |
1984-04-24 |
Bentley Laboratories |
Apparatus and method for measuring blood oxygen saturation
|
|
US4455145A
(en)
|
1981-07-10 |
1984-06-19 |
Alza Corporation |
Dispensing device with internal drive
|
|
AU561343B2
(en)
|
1981-10-19 |
1987-05-07 |
Genentech Inc. |
Human immune interferon by recombinant dna
|
|
EP0079143A3
(en)
|
1981-10-20 |
1984-11-21 |
Adnovum Ag |
Pseudoplastic gel transfer
|
|
EP0080879B1
(en)
|
1981-11-28 |
1986-10-01 |
Sunstar Kabushiki Kaisha |
Pharmaceutical composition containing interferon in stable state
|
|
US5004689A
(en)
|
1982-02-22 |
1991-04-02 |
Biogen, Massachusetts |
DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4455143A
(en)
|
1982-03-22 |
1984-06-19 |
Alza Corporation |
Osmotic device for dispensing two different medications
|
|
US6936694B1
(en)
|
1982-05-06 |
2005-08-30 |
Intermune, Inc. |
Manufacture and expression of large structural genes
|
|
DE3220116A1
(de)
|
1982-05-28 |
1983-12-01 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4753651A
(en)
|
1982-08-30 |
1988-06-28 |
Alza Corporation |
Self-driven pump
|
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
|
US4552561A
(en)
|
1982-12-23 |
1985-11-12 |
Alza Corporation |
Body mounted pump housing and pump assembly employing the same
|
|
US4673405A
(en)
|
1983-03-04 |
1987-06-16 |
Alza Corporation |
Osmotic system with instant drug availability
|
|
US4639244A
(en)
|
1983-05-03 |
1987-01-27 |
Nabil I. Rizk |
Implantable electrophoretic pump for ionic drugs and associated methods
|
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
|
DE3320583A1
(de)
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
|
|
JPS6058915A
(ja)
|
1983-09-12 |
1985-04-05 |
Fujisawa Pharmaceut Co Ltd |
薬物含有脂質小胞体製剤
|
|
US4594108A
(en)
|
1983-09-19 |
1986-06-10 |
The Dow Chemical Company |
Highly pseudoplastic polymer solutions
|
|
US5385738A
(en)
|
1983-10-14 |
1995-01-31 |
Sumitomo Pharmaceuticals Company, Ltd. |
Sustained-release injection
|
|
US4923805A
(en)
|
1983-11-02 |
1990-05-08 |
Integrated Genetics, Inc. |
Fsh
|
|
US4840896A
(en)
|
1983-11-02 |
1989-06-20 |
Integrated Genetics, Inc. |
Heteropolymeric protein
|
|
US5639639A
(en)
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
|
US4855238A
(en)
|
1983-12-16 |
1989-08-08 |
Genentech, Inc. |
Recombinant gamma interferons having enhanced stability and methods therefor
|
|
MX9203641A
(es)
|
1983-12-16 |
1992-07-01 |
Genentech Inc |
Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
|
|
US4851228A
(en)
|
1984-06-20 |
1989-07-25 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic
|
|
US5120832A
(en)
|
1984-08-27 |
1992-06-09 |
Genentech, Inc. |
Distinct family of human leukocyte interferons
|
|
US5231176A
(en)
|
1984-08-27 |
1993-07-27 |
Genentech, Inc. |
Distinct family DNA encoding of human leukocyte interferons
|
|
US4927687A
(en)
|
1984-10-01 |
1990-05-22 |
Biotek, Inc. |
Sustained release transdermal drug delivery composition
|
|
US5411951A
(en)
|
1984-10-04 |
1995-05-02 |
Monsanto Company |
Prolonged release of biologically active somatotropin
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
FI90990C
(fi)
|
1984-12-18 |
1994-04-25 |
Boehringer Ingelheim Int |
Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
|
|
US4655462A
(en)
|
1985-01-07 |
1987-04-07 |
Peter J. Balsells |
Canted coiled spring and seal
|
|
JPS61189230A
(ja)
|
1985-02-19 |
1986-08-22 |
Nippon Kayaku Co Ltd |
エトポシド製剤
|
|
US4609374A
(en)
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
|
EP0205404B1
(en)
|
1985-06-11 |
1992-07-15 |
Ciba-Geigy Ag |
Hybrid interferons
|
|
US4845196A
(en)
|
1985-06-24 |
1989-07-04 |
G. D. Searle & Co. |
Modified interferon gammas
|
|
US4847079A
(en)
|
1985-07-29 |
1989-07-11 |
Schering Corporation |
Biologically stable interferon compositions comprising thimerosal
|
|
IE59361B1
(en)
|
1986-01-24 |
1994-02-09 |
Akzo Nv |
Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
|
|
DE3607835A1
(de)
|
1986-03-10 |
1987-09-24 |
Boehringer Ingelheim Int |
Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
|
|
US4865845A
(en)
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
|
US4737437A
(en)
|
1986-03-27 |
1988-04-12 |
East Shore Chemical Co. |
Light sensitive diazo compound, composition and method of making the composition
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US6849708B1
(en)
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
|
US4755180A
(en)
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
|
DE3636123A1
(de)
|
1986-10-23 |
1988-05-05 |
Rentschler Arzneimittel |
Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
|
|
ZA878295B
(en)
|
1986-11-06 |
1988-05-03 |
Amarillo Cell Culture Co. Inc. |
Treatment of immuno-resistant disease
|
|
CA1320905C
(en)
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
|
DE3642096A1
(de)
|
1986-12-10 |
1988-06-16 |
Boehringer Ingelheim Int |
Pferde-(gamma)-interferon
|
|
US5371089A
(en)
|
1987-02-26 |
1994-12-06 |
Senetek, Plc |
Method and composition for ameliorating the adverse effects of aging
|
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
|
JPH0720866B2
(ja)
|
1987-05-15 |
1995-03-08 |
三生製薬株式会社 |
エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
|
|
US4940465A
(en)
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
|
US4892778A
(en)
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
|
US4874388A
(en)
|
1987-06-25 |
1989-10-17 |
Alza Corporation |
Multi-layer delivery system
|
|
US5023088A
(en)
|
1987-06-25 |
1991-06-11 |
Alza Corporation |
Multi-unit delivery system
|
|
US5938654A
(en)
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
US4915949A
(en)
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
|
EP0303306B1
(en)
|
1987-08-08 |
1993-03-10 |
Akzo N.V. |
Contraceptive implant
|
|
US4915954A
(en)
|
1987-09-03 |
1990-04-10 |
Alza Corporation |
Dosage form for delivering a drug at two different rates
|
|
US5756450A
(en)
|
1987-09-15 |
1998-05-26 |
Novartis Corporation |
Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
|
|
US4886668A
(en)
|
1987-09-24 |
1989-12-12 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic pump
|
|
GB8723846D0
(en)
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
|
WO1989003678A1
(en)
|
1987-10-30 |
1989-05-05 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
|
US4917895A
(en)
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
|
US5160122A
(en)
|
1990-03-20 |
1992-11-03 |
Peter J. Balsells |
Coil spring with an elastomer having a hollow coil cross section
|
|
US4964204A
(en)
|
1988-04-25 |
1990-10-23 |
Peter J. Balsells |
Method for making a garter-type axially-resilient coil spring
|
|
US4961253A
(en)
|
1988-04-25 |
1990-10-09 |
Peter J. Balsells |
Manufacturing method for canted-coil spring with turn angle and seal
|
|
US5079388A
(en)
|
1989-12-01 |
1992-01-07 |
Peter J. Balsells |
Gasket for sealing electromagnetic waves
|
|
US4826144A
(en)
|
1988-04-25 |
1989-05-02 |
Peter J. Balsells |
Inside back angle canted coil spring
|
|
US5117066A
(en)
|
1988-04-25 |
1992-05-26 |
Peter J. Balsells |
Retaining and locking electromagnetic gasket
|
|
US4830344A
(en)
|
1988-04-25 |
1989-05-16 |
Peter J. Balsells |
Canted-coil spring with turn angle and seal
|
|
US5108078A
(en)
|
1988-04-25 |
1992-04-28 |
Peter J. Balsells |
Canted-coil spring loaded while in a cavity
|
|
DE68909295T2
(de)
|
1988-04-25 |
1994-05-11 |
Peter J Balsells |
In sich geschlossene ringförmige Schraubenfeder mit äusserem, rückwärtigem Neigungswinkel.
|
|
US5203849A
(en)
|
1990-03-20 |
1993-04-20 |
Balsells Peter J |
Canted coil spring in length filled with an elastomer
|
|
US4974821A
(en)
|
1988-04-25 |
1990-12-04 |
Peter J. Balsells |
Canted-coil spring with major axis radial loading
|
|
US4907788A
(en)
|
1988-04-25 |
1990-03-13 |
Peter J. Balsells |
Dual concentric canted-coil spring apparatus
|
|
US4893795A
(en)
|
1988-08-15 |
1990-01-16 |
Peter J. Balsells |
Radially loaded canted coiled spring with turn angle
|
|
US5072070A
(en)
|
1989-12-01 |
1991-12-10 |
Peter J. Balsells |
Device for sealing electromagnetic waves
|
|
US4915366A
(en)
|
1988-04-25 |
1990-04-10 |
Peter J. Balsells |
Outside back angle canted coil spring
|
|
US4934666A
(en)
|
1988-04-25 |
1990-06-19 |
Peter J. Balsells |
Coiled spring electromagnetic shielding gasket
|
|
US4876781A
(en)
|
1988-04-25 |
1989-10-31 |
Peter J. Balsells |
Method of making a garter-type axially resilient coiled spring
|
|
US5160743A
(en)
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
|
US4931285A
(en)
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
|
US5006346A
(en)
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
|
US5024842A
(en)
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
|
JP2827287B2
(ja)
|
1988-07-05 |
1998-11-25 |
武田薬品工業株式会社 |
水溶性薬物含有徐放型マイクロカプセル
|
|
JP2794022B2
(ja)
|
1988-11-11 |
1998-09-03 |
三生製薬株式会社 |
ブナゾシン或いはその塩類含有経皮適用製剤
|
|
US5728088A
(en)
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
|
US5057318A
(en)
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
|
US5059423A
(en)
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
|
US5110596A
(en)
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
|
US5234424A
(en)
|
1988-12-28 |
1993-08-10 |
Alza Corporation |
Osmotically driven syringe
|
|
US4969884A
(en)
|
1988-12-28 |
1990-11-13 |
Alza Corporation |
Osmotically driven syringe
|
|
US4976966A
(en)
|
1988-12-29 |
1990-12-11 |
Alza Corporation |
Delayed release osmotically driven fluid dispenser
|
|
IL92344A0
(en)
|
1989-01-04 |
1990-07-26 |
Gist Brocades Nv |
Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
|
|
US5288479A
(en)
|
1989-01-17 |
1994-02-22 |
Sterling Drug, Inc. |
Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
|
|
US5906816A
(en)
|
1995-03-16 |
1999-05-25 |
University Of Florida |
Method for treatment of autoimmune diseases
|
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
|
US5219572A
(en)
|
1989-03-17 |
1993-06-15 |
Pitman-Moore, Inc. |
Controlled release delivery device for macromolecular proteins
|
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
ES2062530T3
(es)
|
1989-05-01 |
1994-12-16 |
Alkermes Inc |
Procedimiento para producir particulas pequeñas de moleculas biologicamente activas.
|
|
DK0471036T4
(da)
|
1989-05-04 |
2004-07-19 |
Southern Res Inst |
Indkapslingsfremgangsmåde
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5126142A
(en)
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
|
US5225205A
(en)
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
|
US5439688A
(en)
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
|
KR920702383A
(ko)
|
1989-08-28 |
1992-09-03 |
원본미기재 |
치료제의 방출을 조절하는데 유용한 생부식성 중합체
|
|
US5112614A
(en)
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
|
US5290558A
(en)
|
1989-09-21 |
1994-03-01 |
Osteotech, Inc. |
Flowable demineralized bone powder composition and its use in bone repair
|
|
SE465950B
(sv)
|
1989-10-23 |
1991-11-25 |
Medinvent Sa |
Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning
|
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
ATE95415T1
(de)
|
1989-11-13 |
1993-10-15 |
Medicorp Holding |
Vorratsbehaelter fuer einen bestandteil einer medikamentenloesung.
|
|
JPH03236317A
(ja)
|
1989-12-06 |
1991-10-22 |
Sansei Seiyaku Kk |
ドパミン誘導体含有経皮用製剤
|
|
US5030216A
(en)
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
|
USD326718S
(en)
|
1989-12-26 |
1992-06-02 |
Minnesota Mining And Manufacturing Co. |
Blood sensor cassette
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
US5213809A
(en)
|
1990-01-24 |
1993-05-25 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
|
US5223266A
(en)
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
|
US5126147A
(en)
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
|
US5478564A
(en)
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
|
US5122128A
(en)
|
1990-03-15 |
1992-06-16 |
Alza Corporation |
Orifice insert for a ruminal bolus
|
|
US5120306A
(en)
|
1990-03-21 |
1992-06-09 |
Gosselin Leon F |
Direct delivery of anti-inflammatories to the proximal small bowel
|
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
|
US5213810A
(en)
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
|
US5324280A
(en)
|
1990-04-02 |
1994-06-28 |
Alza Corporation |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5290271A
(en)
|
1990-05-14 |
1994-03-01 |
Jernberg Gary R |
Surgical implant and method for controlled release of chemotherapeutic agents
|
|
US5374620A
(en)
|
1990-06-07 |
1994-12-20 |
Genentech, Inc. |
Growth-promoting composition and its use
|
|
US5234693A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5180591A
(en)
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5234692A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5234695A
(en)
|
1990-07-24 |
1993-08-10 |
Eastman Kodak Company |
Water dispersible vitamin E composition
|
|
USD329278S
(en)
|
1990-10-01 |
1992-09-08 |
Gallup Allen I |
Infant's bathing support
|
|
US5300302A
(en)
|
1990-10-04 |
1994-04-05 |
Nestec S.A. |
Pharmaceutical composition in gel form in a dispensing package
|
|
US5529914A
(en)
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
|
US5151093A
(en)
|
1990-10-29 |
1992-09-29 |
Alza Corporation |
Osmotically driven syringe with programmable agent delivery
|
|
US5122377A
(en)
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
|
IT1243390B
(it)
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
|
US5161806A
(en)
|
1990-12-17 |
1992-11-10 |
Peter J. Balsells |
Spring-loaded, hollow, elliptical ring seal
|
|
GB9027422D0
(en)
|
1990-12-18 |
1991-02-06 |
Scras |
Osmotically driven infusion device
|
|
IE920040A1
(en)
|
1991-01-09 |
1992-07-15 |
Alza Corp |
Bioerodible devices and compositions for diffusional release¹of agents
|
|
US5443459A
(en)
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
NL9100160A
(nl)
|
1991-01-30 |
1992-08-17 |
Texas Instruments Holland |
Injector.
|
|
US5861166A
(en)
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
|
FI934919L
(fi)
|
1991-05-07 |
1993-12-17 |
Dynagen Inc |
Avgivningssystem med kontrollerad, foerlaengd frigivning foer roekavvaenjning
|
|
US5113938A
(en)
|
1991-05-07 |
1992-05-19 |
Clayton Charley H |
Whipstock
|
|
US5137727A
(en)
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
|
EP0520119A1
(de)
|
1991-06-17 |
1992-12-30 |
Spirig Ag Pharmazeutische Präparate |
Neue orale Diclofenaczubereitung
|
|
US5190765A
(en)
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
|
US5252338A
(en)
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
|
HU222501B1
(hu)
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
|
DE4122217C2
(de)
|
1991-07-04 |
1997-02-13 |
Merz & Co Gmbh & Co |
Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
|
|
US5288214A
(en)
|
1991-09-30 |
1994-02-22 |
Toshio Fukuda |
Micropump
|
|
YU87892A
(sh)
|
1991-10-01 |
1995-12-04 |
Eli Lilly And Company Lilly Corporate Center |
Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
|
|
ATE183642T1
(de)
|
1991-10-04 |
1999-09-15 |
Yoshitomi Pharmaceutical |
Tablette mit verzögerter freisetzung
|
|
EP0607321A1
(en)
|
1991-10-10 |
1994-07-27 |
Alza Corporation |
Osmotic drug delivery devices with hydrophobic wall materials
|
|
US5288502A
(en)
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
|
US5318780A
(en)
|
1991-10-30 |
1994-06-07 |
Mediventures Inc. |
Medical uses of in situ formed gels
|
|
US5236707A
(en)
|
1991-11-08 |
1993-08-17 |
Dallas Biotherapeutics, Inc. |
Stabilization of human interferon
|
|
DE4137649C2
(de)
|
1991-11-15 |
1997-11-20 |
Gerhard Dingler |
Bauelement
|
|
AU3136293A
(en)
|
1991-11-15 |
1993-06-15 |
Isp Investments Inc. |
Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
|
|
US5200195A
(en)
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5223265A
(en)
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
|
US5658593A
(en)
|
1992-01-16 |
1997-08-19 |
Coletica |
Injectable compositions containing collagen microcapsules
|
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
|
US5308348A
(en)
|
1992-02-18 |
1994-05-03 |
Alza Corporation |
Delivery devices with pulsatile effect
|
|
US5209746A
(en)
|
1992-02-18 |
1993-05-11 |
Alza Corporation |
Osmotically driven delivery devices with pulsatile effect
|
|
US5456679A
(en)
|
1992-02-18 |
1995-10-10 |
Alza Corporation |
Delivery devices with pulsatile effect
|
|
US5573934A
(en)
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
|
ES2152248T3
(es)
|
1992-02-28 |
2001-02-01 |
Collagen Corp |
Composiciones de colageno de alta concentracion.
|
|
US5656297A
(en)
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
|
US5221278A
(en)
|
1992-03-12 |
1993-06-22 |
Alza Corporation |
Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
|
|
MX9301821A
(es)
|
1992-03-30 |
1994-03-31 |
Alza Corp |
Sistema de matriz polimerica biodegradable regulador de degradacion y metodo de tratamiento del mismo.
|
|
WO1993019739A1
(en)
|
1992-03-30 |
1993-10-14 |
Alza Corporation |
Viscous suspensions of controlled-release drug particles
|
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
FR2690622B1
(fr)
|
1992-04-29 |
1995-01-20 |
Chronotec |
Système de pompe à perfusion ambulatoire programmable.
|
|
US5314685A
(en)
|
1992-05-11 |
1994-05-24 |
Agouron Pharmaceuticals, Inc. |
Anhydrous formulations for administering lipophilic agents
|
|
US5711968A
(en)
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
|
JP2651320B2
(ja)
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
|
US5413672A
(en)
|
1992-07-22 |
1995-05-09 |
Ngk Insulators, Ltd. |
Method of etching sendust and method of pattern-etching sendust and chromium films
|
|
US5512293A
(en)
|
1992-07-23 |
1996-04-30 |
Alza Corporation |
Oral sustained release drug delivery device
|
|
US5609885A
(en)
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
|
GB9223146D0
(en)
|
1992-11-05 |
1992-12-16 |
Scherer Corp R P |
Vented capsule
|
|
DE69224386T2
(de)
|
1992-11-06 |
1998-06-18 |
Texas Instruments Inc |
Vorrichtung zum subkutanen Einführen einer Nadel
|
|
DE69327542T2
(de)
|
1992-11-17 |
2000-07-06 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
|
|
USD342855S
(en)
|
1992-11-20 |
1994-01-04 |
Butler Ii George D |
Combined infant cushion and cover
|
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
|
SE9203594D0
(sv)
|
1992-11-30 |
1992-11-30 |
Christer Nystroem |
Laekemedel i dispersa system
|
|
CA2150803C
(en)
|
1992-12-02 |
2006-01-31 |
Henry Auer |
Controlled release growth hormone containing microspheres
|
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
|
AU685784B2
(en)
|
1993-02-23 |
1998-01-29 |
Genentech Inc. |
Excipient stabilization of polypeptides treated with organic solvents
|
|
US5368588A
(en)
|
1993-02-26 |
1994-11-29 |
Bettinger; David S. |
Parenteral fluid medication reservoir pump
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
AU6410494A
(en)
|
1993-03-17 |
1994-10-11 |
Alza Corporation |
Device for the transdermal administration of alprazolam
|
|
US5514110A
(en)
|
1993-03-22 |
1996-05-07 |
Teh; Eutiquio L. |
Automatic flow control device
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
HU225496B1
(en)
|
1993-04-07 |
2007-01-29 |
Scios Inc |
Pharmaceutical compositions of prolonged delivery, containing peptides
|
|
TW360548B
(en)
|
1993-04-08 |
1999-06-11 |
Powderject Res Ltd |
Products for therapeutic use
|
|
NZ247516A
(en)
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
US5639477A
(en)
|
1993-06-23 |
1997-06-17 |
Alza Corporation |
Ruminal drug delivery device
|
|
US5919478A
(en)
|
1993-06-25 |
1999-07-06 |
Alza Corporation |
Incorporating poly-N-vinyl amide in a transdermal system
|
|
US5498255A
(en)
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
|
US5385887A
(en)
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
|
JP2700141B2
(ja)
|
1993-09-17 |
1998-01-19 |
富士化学工業株式会社 |
リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤
|
|
JP3688293B2
(ja)
|
1993-09-29 |
2005-08-24 |
アルザ・コーポレーション |
モノグリセリド／乳酸エステル透過促進剤
|
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
|
EP2283821A1
(en)
|
1993-11-19 |
2011-02-16 |
Alkermes, Inc. |
Preparation of biodegradable microparticles containing a biologically active agent
|
|
US5650173A
(en)
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
|
CN1074923C
(zh)
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
|
JPH07196479A
(ja)
|
1994-01-04 |
1995-08-01 |
Unitika Ltd |
マイクロカプセルの製造法
|
|
USD358644S
(en)
|
1994-01-18 |
1995-05-23 |
Bio Medic Data Systems, Inc. |
Transponder implanter
|
|
US6241734B1
(en)
|
1998-08-14 |
2001-06-05 |
Kyphon, Inc. |
Systems and methods for placing materials into bone
|
|
US5540665A
(en)
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
|
CN1083713C
(zh)
|
1994-02-04 |
2002-05-01 |
利珀克尔集团公司 |
双层制剂
|
|
US5697975A
(en)
|
1994-02-09 |
1997-12-16 |
The University Of Iowa Research Foundation |
Human cerebral cortex neural prosthetic for tinnitus
|
|
US5458888A
(en)
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
|
PT741577E
(pt)
|
1994-03-07 |
2003-03-31 |
Imperial College |
Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado
|
|
ZA953078B
(en)
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
|
ATE225647T1
(de)
|
1994-06-13 |
2002-10-15 |
Alza Corp |
Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
|
|
NL9401150A
(nl)
|
1994-07-12 |
1996-02-01 |
Nederland Ptt |
Werkwijze voor het aan een ontvangzijde aanbieden van een van een zendzijde afkomstig eerste aantal videosignalen, alsmede systeem, alsmede zender, alsmede netwerk, en alsmede ontvanger.
|
|
JP4090072B2
(ja)
|
1994-07-13 |
2008-05-28 |
アルザ・コーポレーション |
経皮電気的移送式作用剤投与を促進するための組成物と方法
|
|
US5633011A
(en)
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
EP0788351B1
(en)
|
1994-11-10 |
2003-02-05 |
The University of Kentucky Research Foundation |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
|
|
US5595759A
(en)
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
|
FR2731150B1
(fr)
|
1995-03-03 |
1997-04-18 |
Oreal |
Utilisation de composes amphiphiles en tant qu'agent epaississant de milieux non aqueux
|
|
US5607687A
(en)
|
1995-03-06 |
1997-03-04 |
Ethicon, Inc. |
Polymer blends containing absorbable polyoxaesters
|
|
US5464929A
(en)
|
1995-03-06 |
1995-11-07 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
|
US5700583A
(en)
|
1995-03-06 |
1997-12-23 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters containing amines or amido groups
|
|
US5648088A
(en)
|
1995-03-06 |
1997-07-15 |
Ethicon, Inc. |
Blends of absorbable polyoxaesters containing amines and/or amide groups
|
|
US5962023A
(en)
|
1995-03-06 |
1999-10-05 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides
|
|
US5844017A
(en)
|
1995-03-06 |
1998-12-01 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters containing amines and/or amido groups
|
|
US6147168A
(en)
|
1995-03-06 |
2000-11-14 |
Ethicon, Inc. |
Copolymers of absorbable polyoxaesters
|
|
US5618552A
(en)
|
1995-03-06 |
1997-04-08 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
|
US6403655B1
(en)
|
1995-03-06 |
2002-06-11 |
Ethicon, Inc. |
Method of preventing adhesions with absorbable polyoxaesters
|
|
US5595751A
(en)
|
1995-03-06 |
1997-01-21 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/or amido groups
|
|
US6100346A
(en)
|
1995-03-06 |
2000-08-08 |
Ethicon, Inc. |
Copolymers of polyoxaamides
|
|
US5859150A
(en)
|
1995-03-06 |
1999-01-12 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters
|
|
US5698213A
(en)
|
1995-03-06 |
1997-12-16 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters
|
|
US5597579A
(en)
|
1995-03-06 |
1997-01-28 |
Ethicon, Inc. |
Blends of absorbable polyoxaamides
|
|
IL113100A0
(en)
|
1995-03-23 |
1995-06-29 |
Schatz Anat |
Infant's mattress
|
|
US5542682A
(en)
|
1995-03-27 |
1996-08-06 |
American Variseal |
Slant coil spring and seal
|
|
US5736159A
(en)
|
1995-04-28 |
1998-04-07 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
|
|
US5972373A
(en)
|
1995-05-02 |
1999-10-26 |
Taisho Pharmaceutical Co., Ltd. |
Taste masking pharmaceutical composition for oral administration
|
|
US5939286A
(en)
|
1995-05-10 |
1999-08-17 |
University Of Florida |
Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
|
|
US5922253A
(en)
|
1995-05-18 |
1999-07-13 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
|
US5882676A
(en)
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
|
US5718922A
(en)
|
1995-05-31 |
1998-02-17 |
Schepens Eye Research Institute, Inc. |
Intravitreal microsphere drug delivery and method of preparation
|
|
ES2182996T3
(es)
|
1995-06-06 |
2003-03-16 |
Hoffmann La Roche |
Composiciones farmaceuticas que comprenden un inhibidor de proteinasa y un monglicerido.
|
|
US5690952A
(en)
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
|
CN1188189C
(zh)
|
1995-06-07 |
2005-02-09 |
奥瑟－麦内尔制药公司 |
基质层含有17－脱乙酰基诺孕酯的经皮贴片及基质的用途
|
|
US6129761A
(en)
|
1995-06-07 |
2000-10-10 |
Reprogenesis, Inc. |
Injectable hydrogel compositions
|
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5904935A
(en)
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US6572879B1
(en)
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
|
US5782396A
(en)
|
1995-08-28 |
1998-07-21 |
United States Surgical Corporation |
Surgical stapler
|
|
US5906830A
(en)
|
1995-09-08 |
1999-05-25 |
Cygnus, Inc. |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
|
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
|
GB9521125D0
(en)
|
1995-10-16 |
1995-12-20 |
Unilever Plc |
Cosmetic composition
|
|
SE505146C2
(sv)
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
|
US5766620A
(en)
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
|
GB9521805D0
(en)
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Solubilisation methods
|
|
DE69626927T2
(de)
|
1995-10-30 |
2003-11-20 |
Oleoyl-Estrone Developments, S.I. |
Oleat Monoester von Estrogenen zur Behandlung von Fettleibigkeit
|
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
|
DE69632062T2
(de)
|
1995-11-02 |
2004-11-18 |
Schering Corp. |
Kontinuierliche, niedrigdosierte zytokine-infusionstherapie
|
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
|
AUPN723395A0
(en)
|
1995-12-19 |
1996-01-18 |
Macnaught Medical Pty Limited |
Lubrication methods
|
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
DE69625623T2
(de)
|
1996-01-31 |
2003-11-06 |
Sumitomo Bakelite Co. Ltd., Tokio/Tokyo |
Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
|
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US6132420A
(en)
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
AU2526497A
(en)
|
1996-02-02 |
1997-08-22 |
Rhomed Incorporated |
Post-labeling stabilization of radiolabeled proteins and peptides
|
|
NZ331186A
(en)
|
1996-02-02 |
2000-04-28 |
Alza Corp |
Osmotically driven sustained delivery drug delivery capsule
|
|
US6156331A
(en)
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6245349B1
(en)
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
|
DE69740176D1
(de)
|
1996-03-01 |
2011-05-26 |
Novo Nordisk As |
Appetithemmendes Peptid, Zusammensetzung und Verwendung
|
|
JPH09241153A
(ja)
|
1996-03-04 |
1997-09-16 |
Q P Corp |
静脈注射用脂肪乳剤
|
|
EP0888350A1
(en)
|
1996-03-08 |
1999-01-07 |
Zeneca Limited |
Azolobenzazepine derivatives as neurologically active agents
|
|
WO1997033998A1
(en)
|
1996-03-14 |
1997-09-18 |
The Immune Response Corporation |
Targeted delivery of genes encoding interferon
|
|
US5703200A
(en)
|
1996-03-15 |
1997-12-30 |
Ethicon, Inc. |
Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
|
|
US6190702B1
(en)
|
1996-03-28 |
2001-02-20 |
Takeda Chemical Industries, Ltd. |
Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
|
|
US5660858A
(en)
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
|
US6204022B1
(en)
|
1996-04-12 |
2001-03-20 |
Pepgen Corporation And University Of Florida |
Low-toxicity human interferon-alpha analogs
|
|
US6074673A
(en)
|
1996-04-22 |
2000-06-13 |
Guillen; Manuel |
Slow-release, self-absorbing, drug delivery system
|
|
US5976109A
(en)
|
1996-04-30 |
1999-11-02 |
Medtronic, Inc. |
Apparatus for drug infusion implanted within a living body
|
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
|
TW487572B
(en)
|
1996-05-20 |
2002-05-21 |
Janssen Pharmaceutica Nv |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
|
WO1997046584A1
(de)
|
1996-06-05 |
1997-12-11 |
Boehringer Mannheim Gmbh |
Exendin-analoga, verfahren zu deren herstellung und diese enthaltende arzneimittel
|
|
CA2259469A1
(en)
|
1996-06-05 |
1997-12-11 |
Ashmont Holdings Limited |
Injectable compositions
|
|
DE29610419U1
(de)
|
1996-06-14 |
1996-10-24 |
Filtertek, S.A., Plailly |
Schwerkraftinfusionsvorrichtung für medizinische Infusionen
|
|
GB9613858D0
(en)
|
1996-07-02 |
1996-09-04 |
Cortecs Ltd |
Hydrophobic preparations
|
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
|
AU737664B2
(en)
|
1996-07-03 |
2001-08-30 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
|
US5916582A
(en)
|
1996-07-03 |
1999-06-29 |
Alza Corporation |
Aqueous formulations of peptides
|
|
ES2227707T3
(es)
|
1996-07-15 |
2005-04-01 |
Alza Corporation |
Nuevas formulaciones para la administracion transdermica de acetato de fluoxetina y de maleato de fluoxetina.
|
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
|
ATE493998T1
(de)
|
1996-08-08 |
2011-01-15 |
Amylin Pharmaceuticals Inc |
Pharmazeutische zusammensetzung mit einem exendin-4-peptid
|
|
WO1998007412A1
(en)
|
1996-08-21 |
1998-02-26 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release microparticles with a hydrophobic material
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US5984890A
(en)
|
1996-09-27 |
1999-11-16 |
American Home Products Corporation |
Medical device for the placement of solid materials
|
|
IN184589B
(2)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
CA2264687C
(en)
|
1996-10-24 |
2006-04-25 |
Alza Corporation |
Permeation enhancers for transdermal drug delivery compositions, devices, and methods
|
|
US5817129A
(en)
|
1996-10-31 |
1998-10-06 |
Ethicon, Inc. |
Process and apparatus for coating surgical sutures
|
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
DE19646392A1
(de)
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
|
US5928666A
(en)
|
1996-11-12 |
1999-07-27 |
Cygnus Inc. |
Crystalline form of estradiol and pharmaceutical formulations comprising same
|
|
WO1998020930A1
(en)
|
1996-11-15 |
1998-05-22 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
|
JP4642946B2
(ja)
|
1996-12-20 |
2011-03-02 |
アルザ コーポレイション |
ゲル組成物および方法
|
|
GB9626513D0
(en)
|
1996-12-20 |
1997-02-05 |
Bioglan Ireland R & D Ltd |
A pharmaceutical composition
|
|
DE122007000044I2
(de)
|
1997-01-07 |
2011-05-05 |
Amylin Pharmaceuticals Inc |
Verwendung von exedinen und deren antagonisten zur verminderung der lebensmittelaufnahme
|
|
JP2001511128A
(ja)
|
1997-01-28 |
2001-08-07 |
ファルマシア・アンド・アップジョン・カンパニー |
水不溶性ポルフィリンの脂質錯体の凍結乾燥物
|
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
|
ZA981610B
(en)
|
1997-03-24 |
1999-08-26 |
Alza Corp |
Self adjustable exit port.
|
|
US5874388A
(en)
|
1997-04-02 |
1999-02-23 |
Dow Corning Corporation |
Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant
|
|
US6127520A
(en)
|
1997-04-15 |
2000-10-03 |
Regents Of The University Of Michigan |
Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles
|
|
AU6919598A
(en)
|
1997-04-17 |
1998-11-13 |
Dumex-Alpharma A/S |
A novel bioadhesive drug delivery system based on liquid crystals
|
|
MY118835A
(en)
|
1997-04-18 |
2005-01-31 |
Ipsen Pharma Biotech |
Sustained release compositions and the process for their preparation
|
|
WO1998049321A2
(en)
|
1997-04-28 |
1998-11-05 |
Rhone-Poulenc Rorer S.A. |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
|
US20020039594A1
(en)
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
|
US6113947A
(en)
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
|
MY125849A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
|
MY125870A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
GB9718986D0
(en)
|
1997-09-09 |
1997-11-12 |
Danbiosyst Uk |
Controlled release microsphere delivery system
|
|
US6023802A
(en)
|
1997-09-10 |
2000-02-15 |
King; Susan Melton |
Infant sleeper
|
|
US6172046B1
(en)
|
1997-09-21 |
2001-01-09 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
AU756693B2
(en)
|
1997-09-29 |
2003-01-23 |
Novartis Ag |
Stabilized bioactive preparations and methods of use
|
|
JPH11100353A
(ja)
|
1997-09-29 |
1999-04-13 |
Esupo Kk |
精製・脱臭液状エステルワックスとその組成物
|
|
US6133429A
(en)
|
1997-10-03 |
2000-10-17 |
Becton Dickinson And Company |
Chromophores useful for the preparation of novel tandem conjugates
|
|
USD399821S
(en)
|
1997-11-07 |
1998-10-20 |
Motorola, Inc. |
Front section of a battery charger
|
|
ATE383867T1
(de)
|
1997-11-14 |
2008-02-15 |
Amylin Pharmaceuticals Inc |
Neuartige exendin agonisten
|
|
EP1037995A1
(en)
|
1997-12-08 |
2000-09-27 |
Genentech, Inc. |
Human interferon-epsilon: a type 1 interferon
|
|
US6368612B1
(en)
|
1997-12-12 |
2002-04-09 |
Biohybrid Technologies Llc |
Devices for cloaking transplanted cells
|
|
AU1623099A
(en)
|
1997-12-22 |
1999-07-12 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
|
PT1044032E
(pt)
|
1997-12-29 |
2004-08-31 |
Alza Corp |
Dispositivo de implantacao para implantes sebcutaneos
|
|
WO1999033446A1
(en)
|
1997-12-29 |
1999-07-08 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
|
DK1300129T3
(da)
|
1997-12-29 |
2005-06-20 |
Alza Corp |
Implantathætteglas
|
|
KR100568917B1
(ko)
|
1997-12-30 |
2006-04-07 |
알자 코포레이션 |
멤브레인 플러그를 갖는 익제 전달장치
|
|
US20040024068A1
(en)
|
1998-01-23 |
2004-02-05 |
Trustees Of Tufts College |
Antimicrobial compounds
|
|
IT1298575B1
(it)
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
|
|
US6017545A
(en)
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
EP1054594B1
(en)
|
1998-02-13 |
2007-07-04 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and glp-1
|
|
USD408917S
(en)
|
1998-02-26 |
1999-04-27 |
Minnesota Mining And Manufacturing Company |
Membrane support structure of a flow through cell for blood gas measurement
|
|
US6224577B1
(en)
|
1998-03-02 |
2001-05-01 |
Medrad, Inc. |
Syringes and plungers for use therein
|
|
US6056718A
(en)
|
1998-03-04 |
2000-05-02 |
Minimed Inc. |
Medication infusion set
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6183461B1
(en)
|
1998-03-11 |
2001-02-06 |
Situs Corporation |
Method for delivering a medication
|
|
EP0984039A4
(en)
|
1998-03-12 |
2002-01-02 |
Daicel Chem |
RESIN COMPOSITION CONTAINING LACTON THEREOF MOLDED OBJECT AND FILM
|
|
US6029361A
(en)
|
1998-03-25 |
2000-02-29 |
Ultratech Stepper, Inc. |
Air-guage nozzle probe structure for microlithographic image focusing
|
|
US6074660A
(en)
|
1998-04-20 |
2000-06-13 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/ or amido groups
|
|
TW586944B
(en)
|
1998-05-29 |
2004-05-11 |
Sumitomo Pharma |
Controlled release agent having a multi-layer structure
|
|
US8626302B2
(en)
|
1998-06-03 |
2014-01-07 |
Spr Therapeutics, Llc |
Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
|
|
MXPA00012286A
(es)
|
1998-06-12 |
2002-10-17 |
Bionebraska Inc |
Peptide-1 similar a glucagon mejora la respuesta celular beta a glucosa en sujetos con tolerancia danada de glucosa.
|
|
IL140899A0
(en)
|
1998-07-17 |
2002-02-10 |
Skyepharma Inc |
Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
|
|
US6472512B1
(en)
|
1998-07-21 |
2002-10-29 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
|
US7390637B2
(en)
|
1998-07-21 |
2008-06-24 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
|
US6270700B1
(en)
|
1998-07-23 |
2001-08-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Encapsulation of water soluble peptides
|
|
USD415073S
(en)
|
1998-08-17 |
1999-10-12 |
ScooterBug, Inc. |
Stroller
|
|
US6720407B1
(en)
|
1998-08-28 |
2004-04-13 |
Eli Lilly And Company |
Method for administering insulinotropic peptides
|
|
US6551613B1
(en)
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
|
HK1038508B
(en)
|
1998-09-09 |
2006-06-30 |
Alza Corporation |
Dosage form comprising liquid formulation
|
|
US6174547B1
(en)
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
|
US6248112B1
(en)
|
1998-09-30 |
2001-06-19 |
C. R. Bard, Inc. |
Implant delivery system
|
|
US6284725B1
(en)
|
1998-10-08 |
2001-09-04 |
Bionebraska, Inc. |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
|
|
IL142807A0
(en)
|
1998-11-02 |
2002-03-10 |
Alza Corp |
Controlled delivery of active agents
|
|
WO2000029206A1
(en)
|
1998-11-13 |
2000-05-25 |
Sensor Technologies Inc. |
Monodisperse preparations useful with implanted devices
|
|
US20030060425A1
(en)
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
|
CZ295044B6
(cs)
|
1998-12-07 |
2005-05-18 |
Societe De Conseils De Recherches Et D'application |
Analogy GLP-1, mající kyselinu aminoizomáselnou na pozicích 8 a 35, jejich použití a farmaceutické prostředky je obsahující
|
|
PT1140012E
(pt)
|
1998-12-17 |
2004-05-31 |
Alza Corp |
Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
|
|
JP2002533378A
(ja)
|
1998-12-23 |
2002-10-08 |
アムジエン・インコーポレーテツド |
タンパク質の徐放用ポリオール／油懸濁液
|
|
EP1140014B1
(en)
|
1998-12-31 |
2003-03-19 |
Alza Corporation |
Osmotic delivery system having space efficient piston
|
|
US6433144B1
(en)
|
1999-01-12 |
2002-08-13 |
Viragen, Inc. |
Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
|
|
WO2000039280A2
(en)
|
1998-12-31 |
2000-07-06 |
Viragen, Inc. |
Leukocyte-derived interferon preparations
|
|
WO2000040273A2
(en)
|
1999-01-08 |
2000-07-13 |
Vical Incorporated |
Treatment of viral diseases using an interferon omega expressing polynucleotide
|
|
US6703225B1
(en)
|
1999-01-12 |
2004-03-09 |
Sumitomo Pharmaceuticals Company, Limited |
Interferon-α
|
|
US7399489B2
(en)
|
1999-01-14 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Exendin analog formulations
|
|
ES2278589T3
(es)
|
1999-01-14 |
2007-08-16 |
Amylin Pharmaceuticals, Inc. |
Excendinas destinadas a la inhibicion de glucagon.
|
|
US6902744B1
(en)
|
1999-01-14 |
2005-06-07 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist formulations and methods of administration thereof
|
|
CA2361424C
(en)
|
1999-02-08 |
2009-04-28 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
|
US6451974B1
(en)
|
1999-03-17 |
2002-09-17 |
Novo Nordisk A/S |
Method of acylating peptides and novel acylating agents
|
|
US6835194B2
(en)
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
|
US6541021B1
(en)
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
|
DE60026982T2
(de)
|
1999-04-05 |
2006-11-16 |
Mannkind Corp., Danbury |
Verfahren zur bildung von feinem pulver
|
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
|
CA2306039A1
(en)
|
1999-04-19 |
2000-10-19 |
Schering Corporation |
Hcv combination therapy
|
|
US6924264B1
(en)
|
1999-04-30 |
2005-08-02 |
Amylin Pharmaceuticals, Inc. |
Modified exendins and exendin agonists
|
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
|
BR0010354A
(pt)
|
1999-05-07 |
2002-03-05 |
Pharmasol Gmbh |
Partìculas de lipìdeo à base em misturas de lipìdeos lìquidos e sólidos e método para a sua produção
|
|
US6849714B1
(en)
|
1999-05-17 |
2005-02-01 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
BR0010750A
(pt)
|
1999-05-17 |
2002-02-26 |
Conjuchem Inc |
Peptìdeos insulinotrópicos de longa duração
|
|
US6514500B1
(en)
|
1999-10-15 |
2003-02-04 |
Conjuchem, Inc. |
Long lasting synthetic glucagon like peptide {GLP-!}
|
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
|
US20030059376A1
(en)
|
1999-06-04 |
2003-03-27 |
Libbey Miles A. |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
|
CA2372994C
(en)
|
1999-06-04 |
2010-03-23 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
|
US6485706B1
(en)
|
1999-06-04 |
2002-11-26 |
Delrx Pharmaceutical Corp. |
Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same
|
|
US20010040326A1
(en)
|
1999-06-14 |
2001-11-15 |
Lord Corporation |
Resilient member with deformed element and method of forming same
|
|
US6833256B1
(en)
|
1999-06-22 |
2004-12-21 |
University Of Maryland |
Interferon tau mutants and methods for making them
|
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
USD445975S1
(en)
|
1999-08-27 |
2001-07-31 |
Black & Decker, Inc. |
Base unit for a hand held vacuum cleaner
|
|
SE9903236D0
(sv)
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method to obtain microparticles
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
|
US6436091B1
(en)
|
1999-11-16 |
2002-08-20 |
Microsolutions, Inc. |
Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
|
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
|
AU2092701A
(en)
|
1999-12-17 |
2001-06-25 |
Durect Corporation |
Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide
|
|
ES2248156T3
(es)
|
1999-12-21 |
2006-03-16 |
Alza Corporation |
Valvula para dispositivos osmoticos.
|
|
US6498193B2
(en)
|
1999-12-22 |
2002-12-24 |
Trustees Of Dartmouth College |
Treatment for complications of type 2 diabetes
|
|
US6283949B1
(en)
|
1999-12-27 |
2001-09-04 |
Advanced Cardiovascular Systems, Inc. |
Refillable implantable drug delivery pump
|
|
US6572890B2
(en)
|
2000-01-13 |
2003-06-03 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
|
US6472060B1
(en)
|
2000-01-19 |
2002-10-29 |
Seco Tools Ab |
Coated body with nanocrystalline CVD coating for enhanced edge toughness and reduced friction
|
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
|
US6471688B1
(en)
|
2000-02-15 |
2002-10-29 |
Microsolutions, Inc. |
Osmotic pump drug delivery systems and methods
|
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
|
CN1487836A
(zh)
|
2000-03-14 |
2004-04-07 |
埃米林药品公司 |
胰高糖素样肽1(7-36)对胃窦幽门十二指肠能动性的影响
|
|
US20030211974A1
(en)
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
|
TWI250874B
(en)
|
2000-03-24 |
2006-03-11 |
Nat Health Research Institutes |
Pharmaceutical compositions for preventing or treating disorders associated with bacterial or viral infection
|
|
US6992065B2
(en)
|
2000-04-19 |
2006-01-31 |
Genentech, Inc. |
Sustained release formulations
|
|
US6875748B2
(en)
|
2000-04-21 |
2005-04-05 |
Vical Incorporated |
Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
|
|
CN103356996A
(zh)
|
2000-05-19 |
2013-10-23 |
埃米林药品公司 |
Glp-1用于制备治疗急性冠脉综合征的药物的用途
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
JP4716641B2
(ja)
|
2000-06-16 |
2011-07-06 |
イーライ リリー アンド カンパニー |
グルカゴン様ペプチド−１類似体
|
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
|
US6547250B1
(en)
|
2000-08-21 |
2003-04-15 |
Westport Research Inc. |
Seal assembly with two sealing mechanisms for providing static and dynamic sealing
|
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
|
AU2001296770A1
(en)
|
2000-10-06 |
2002-04-15 |
Durect Corporation |
Devices and methods for management of inflammation
|
|
IL155730A0
(en)
|
2000-11-03 |
2003-11-23 |
Biomedicines Inc |
Method for short-term and long-term drug dosimetry
|
|
EP1335704A2
(en)
|
2000-11-16 |
2003-08-20 |
Durect Corporation |
Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
|
|
JP4248236B2
(ja)
|
2000-11-29 |
2009-04-02 |
デュレクト コーポレイション |
薬物送達装置からの送達を制御するための装置および方法
|
|
US20020165286A1
(en)
|
2000-12-08 |
2002-11-07 |
Hanne Hedeman |
Dermal anti-inflammatory composition
|
|
AU2002228608A1
(en)
|
2000-12-13 |
2002-06-24 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
|
AU3938402A
(en)
|
2000-12-13 |
2002-06-24 |
Lilly Co Eli |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
|
EP2123293A3
(en)
|
2000-12-14 |
2010-09-08 |
Amylin Pharmaceuticals, Inc. |
Peptide YY and petide YY agonists for treatment of metabolic disorders
|
|
WO2002049620A2
(en)
|
2000-12-21 |
2002-06-27 |
Inhale Therapeutic Systems, Inc. |
Induced phase transition method for the production of microparticles containing hydrophobic active agents
|
|
USD472896S1
(en)
|
2000-12-23 |
2003-04-08 |
Andreas Peiker |
Telephone support
|
|
IN188924B
(2)
|
2001-03-01 |
2002-11-23 |
Bharat Serums & Vaccines Ltd |
|
|
EP1379197A4
(en)
|
2001-03-23 |
2009-06-03 |
Durect Corp |
DISPOSAL OF MEDICINAL PRODUCTS OF DELAYED RELEASE DEVICES IMPLANTED IN MYOKARD TISSUE OR PER ICARDROOM
|
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
|
AU2002308706A1
(en)
|
2001-06-01 |
2002-12-16 |
Eli Lilly And Company |
Glp-1 formulations with protracted time action
|
|
US6514517B2
(en)
|
2001-06-20 |
2003-02-04 |
Ethicon, Inc. |
Antimicrobial coatings for medical devices
|
|
JP4460892B2
(ja)
|
2001-06-21 |
2010-05-12 |
ジェネンテック インコーポレイテッド |
徐放性組成物
|
|
ATE478656T1
(de)
|
2001-06-22 |
2010-09-15 |
Univ Johns Hopkins Med |
Biologisch abbaubare polymerzusammensetzungen, zusammensetzungen und damit in beziehung stehende verwendungen
|
|
BR0210520A
(pt)
|
2001-06-22 |
2004-06-22 |
Pfizer Prod Inc |
Composições farmacêuticas de dispersões de fármacos amorfos misturados com polìmeros
|
|
US7163688B2
(en)
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
|
US20030138403A1
(en)
|
2001-06-29 |
2003-07-24 |
Maxygen Aps |
Interferon formulations
|
|
WO2003007981A1
(en)
|
2001-07-20 |
2003-01-30 |
Intermune, Inc. |
Methods of treating liver fibrosis
|
|
ATE408414T1
(de)
|
2001-07-31 |
2008-10-15 |
Us Gov Health & Human Serv |
Glp 1 exendin 4 peptidanaloga und deren verwendungen
|
|
AU2002322403A1
(en)
|
2001-08-23 |
2003-03-10 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
|
US20030064095A1
(en)
|
2001-09-14 |
2003-04-03 |
Imedd, Inc. |
Microfabricated nanopore device for sustained release of therapeutic agent
|
|
ATE443513T1
(de)
|
2001-09-17 |
2009-10-15 |
Durect Corp |
Vorrichtung und verfahren zur genauen abgabe eines wirkstoffs
|
|
CN100350968C
(zh)
|
2001-09-24 |
2007-11-28 |
皇家创新有限公司 |
饮食行为的改进
|
|
CN1738635A
(zh)
|
2001-10-05 |
2006-02-22 |
印特缪恩股份有限公司 |
用多阶段干扰素传递曲线治疗肝炎病毒感染的方法
|
|
US7041646B2
(en)
|
2001-10-05 |
2006-05-09 |
Bayer Pharmaceuticals Corporation |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
|
|
JP4398728B2
(ja)
|
2001-10-24 |
2010-01-13 |
メド−エル・エレクトロメディツィニシェ・ゲラーテ・ゲーエムベーハー |
埋込み式流体配送装置と埋込み式電極
|
|
US20040142902A1
(en)
|
2001-11-08 |
2004-07-22 |
Struijker- Boudier Harry A.J. |
Implant dosage form and use thereof for the delivery of a cholosterol lowering agent
|
|
CA2466228A1
(en)
|
2001-11-09 |
2003-08-07 |
Biomedicines, Inc. |
Method for treating diseases with omega interferon
|
|
EP1446101B1
(en)
|
2001-11-14 |
2011-03-23 |
Durect Corporation |
Catheter injectable depot compositions and uses thereof
|
|
JP5170935B2
(ja)
|
2001-11-14 |
2013-03-27 |
デュレクト コーポレーション |
注入可能なデポー組成物
|
|
DE60239952D1
(de)
|
2001-11-14 |
2011-06-16 |
Durect Corp |
Injizierbare depotzusammensetzungen und deren verwendung
|
|
DE10159217A1
(de)
|
2001-11-27 |
2003-06-05 |
Schering Ag |
17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
|
|
US20030108608A1
(en)
|
2001-12-12 |
2003-06-12 |
Erik Laridon |
Thermoplastic articles comprising silver-containing antimicrobials and high amounts of carboxylic acid salts for increased surface-available silver
|
|
CA2471081A1
(en)
|
2001-12-19 |
2003-07-03 |
Alza Corporation |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
US8058233B2
(en)
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
|
US7105489B2
(en)
|
2002-01-22 |
2006-09-12 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for treating polycystic ovary syndrome
|
|
WO2003066585A2
(en)
|
2002-02-08 |
2003-08-14 |
Alkermes Controlled Therapeutics, Inc. |
Polymer-based compositions for sustained release
|
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
DE60335608D1
(de)
|
2002-02-27 |
2011-02-17 |
Pharmain Corp |
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
|
|
GB2386066A
(en)
|
2002-02-28 |
2003-09-10 |
Norbrook Lab Ltd |
Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
|
|
GB0204722D0
(en)
|
2002-02-28 |
2002-04-17 |
Norferm Da |
Method
|
|
WO2003087335A2
(en)
|
2002-04-11 |
2003-10-23 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by spray drying
|
|
SI2561860T1
(en)
|
2002-05-31 |
2018-05-31 |
Titan Pharmaceuticals, Inc. |
An implantable polymeric device for prolonged release of buprenorphine
|
|
WO2003105803A1
(en)
|
2002-06-17 |
2003-12-24 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
DE60317225T2
(de)
|
2002-06-26 |
2008-05-29 |
Intarcia Therapeutics, Inc., Emeryville |
Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme
|
|
US7177526B2
(en)
|
2002-06-28 |
2007-02-13 |
Intel Corporation |
System and method for improving audio during post-production of video recordings
|
|
AU2002359397B2
(en)
|
2002-07-31 |
2009-01-29 |
Durect Corporation |
Injectable depot compositions and uses thereof
|
|
CN1684663A
(zh)
|
2002-07-31 |
2005-10-19 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
|
US20080260838A1
(en)
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
|
AU2003267327A1
(en)
|
2002-09-04 |
2004-03-29 |
Ruark Botha |
Device for securing a blood vessel cannula to a body
|
|
WO2004035762A2
(en)
|
2002-10-17 |
2004-04-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
|
US20040121009A1
(en)
|
2002-10-17 |
2004-06-24 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
|
AU2003283004A1
(en)
|
2002-10-22 |
2004-05-13 |
Waratah Pharmaceuticals, Inc. |
Treatment of diabetes
|
|
RU2355385C2
(ru)
|
2002-11-06 |
2009-05-20 |
Алза Корпорейшн |
Композиции пролонгированного действия с контролируемым высвобождением
|
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
|
US7014636B2
(en)
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
|
US7790681B2
(en)
|
2002-12-17 |
2010-09-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of cardiac arrhythmias with GLP-1 receptor ligands
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
MXPA05006604A
(es)
|
2002-12-19 |
2006-05-25 |
Alza Corp |
Geles de una sola fase, no acuosos, estables, y formulaciones de los mismos para el suministro desde un aparato implantable.
|
|
GB0300571D0
(en)
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
|
JP2004238392A
(ja)
|
2003-01-14 |
2004-08-26 |
Nipro Corp |
安定化された蛋白質性製剤
|
|
WO2004075349A2
(en)
|
2003-02-18 |
2004-09-02 |
Medconx, Inc. |
Male medical device electrical connector with engineered friction fit
|
|
DE602004012081T2
(de)
|
2003-03-31 |
2009-03-19 |
Intarcia Therapeutics, Inc., Emeryville |
Osmotische pumpe mit mitteln zum ableiten des innendrucks
|
|
TW200509999A
(en)
|
2003-03-31 |
2005-03-16 |
Alza Corp |
Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
|
|
CN1767815A
(zh)
|
2003-03-31 |
2006-05-03 |
阿尔萨公司 |
非水单相载体和使用这类载体的制剂
|
|
EP1626752A2
(de)
|
2003-05-16 |
2006-02-22 |
Blue Membranes GmbH |
Biokompatibel beschichtete medizinische implantate
|
|
WO2004103342A2
(en)
|
2003-05-16 |
2004-12-02 |
Alkermes Controlled Therapeutics, Inc. |
Injectable sustained release compositions
|
|
CA2527664A1
(en)
|
2003-05-30 |
2004-12-16 |
Alza Corporation |
Implantable elastomeric depot compositions, uses thereof and method of manufacturing
|
|
EP1631308B1
(en)
|
2003-05-30 |
2013-07-31 |
Amylin Pharmaceuticals, LLC |
Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
|
KR101308912B1
(ko)
|
2003-06-03 |
2013-09-23 |
노보 노르디스크 에이/에스 |
안정화된 약학적 펩티드 조성물
|
|
US8491571B2
(en)
|
2003-06-12 |
2013-07-23 |
Cordis Corporation |
Orifice device having multiple channels with varying flow rates for drug delivery
|
|
US7454765B2
(en)
|
2003-07-09 |
2008-11-18 |
Samsung Electronics Co., Ltd. |
Optical disc drive
|
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
MXPA06002967A
(es)
|
2003-09-30 |
2006-06-14 |
Alza Corp |
Aparato de suministro de agente activo de conduccion osmotica que proporciona perfil de liberacion ascendente.
|
|
US9005244B2
(en)
|
2003-09-30 |
2015-04-14 |
Ethicon, Inc. |
Tissue approximation device
|
|
AU2004287402A1
(en)
|
2003-10-31 |
2005-05-19 |
Alza Corporation |
Osmotic pump with self-retaining, fast-start membrane plug
|
|
PL379736A1
(pl)
|
2003-11-06 |
2006-11-13 |
Alza Corporation |
Modułowy reduktor prędkości wchłaniania do stosowania z wszczepianą pompą osmotyczną
|
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
|
US20050281879A1
(en)
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US20050106214A1
(en)
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US7780973B2
(en)
|
2003-12-15 |
2010-08-24 |
Ethicon Endo-Surgery, Inc. |
Method and device for minimally invasive implantation of biomaterial
|
|
US20050216087A1
(en)
|
2004-01-05 |
2005-09-29 |
St. Francis Medical Technologies, Inc. |
Disk repair structures for positioning disk repair material
|
|
US20050175701A1
(en)
|
2004-02-10 |
2005-08-11 |
Alza Corporation |
Capillary moderator for osmotic delivery system
|
|
US8076288B2
(en)
|
2004-02-11 |
2011-12-13 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides having glucose lowering activity
|
|
NZ579621A
(en)
|
2004-02-11 |
2011-03-31 |
Amylin Pharmaceuticals Inc |
Hybrid polypeptides with selectable properties
|
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
|
US8617613B2
(en)
|
2004-04-15 |
2013-12-31 |
Alkermes Pharma Ireland Limited |
Polymer-based sustained release device
|
|
WO2005112977A2
(en)
|
2004-04-23 |
2005-12-01 |
Pharmain, Ltd. |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
US20050266087A1
(en)
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
|
WO2006000567A2
(en)
|
2004-06-28 |
2006-01-05 |
Novo Nordisk A/S |
Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function
|
|
US7772182B2
(en)
|
2004-08-05 |
2010-08-10 |
Alza Corporation |
Stable suspension formulations of erythropoietin receptor agonists
|
|
WO2006023526A2
(en)
|
2004-08-18 |
2006-03-02 |
Waters Investments Limited |
Defined leak path for high pressure seal
|
|
US8268791B2
(en)
|
2004-08-25 |
2012-09-18 |
Aegis Therapeutics, Llc. |
Alkylglycoside compositions for drug administration
|
|
WO2006034435A2
(en)
|
2004-09-21 |
2006-03-30 |
Point Therapeutics, Inc. |
Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
|
|
KR101341359B1
(ko)
|
2004-10-01 |
2013-12-13 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US7442682B2
(en)
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
|
CN101094689B
(zh)
|
2004-11-01 |
2013-06-12 |
安米林药品有限责任公司 |
治疗肥胖以及肥胖相关疾病和病症的方法
|
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
|
US7575579B2
(en)
|
2004-11-18 |
2009-08-18 |
Union Surgical, Llc |
Drill guide tissue protector
|
|
US20060141040A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
|
US20060142234A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
|
EP1841448A2
(en)
|
2004-12-30 |
2007-10-10 |
Diakine Therapeutics, Inc. |
Pharmaceutical compositions and methods for restoring beta-cell mass and function
|
|
USD587374S1
(en)
|
2005-01-14 |
2009-02-24 |
Edwards Lifesciences Corporation |
Sensor case
|
|
WO2006077242A1
(en)
|
2005-01-24 |
2006-07-27 |
N.V. Organon |
Applicator for inserting an implant
|
|
WO2006081279A2
(en)
|
2005-01-25 |
2006-08-03 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US20060216242A1
(en)
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
|
US7655254B2
(en)
|
2005-02-03 |
2010-02-02 |
Intarcia Therapeutics, Inc. |
Implantable device for continuous delivery of interferon
|
|
WO2006086727A2
(en)
|
2005-02-09 |
2006-08-17 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
|
KR20070115947A
(ko)
|
2005-02-11 |
2007-12-06 |
아밀린 파마슈티칼스, 인크. |
선택가능한 특성들을 가지는 ｇｉｐ 유사체 및 하이브리드폴리펩타이드
|
|
WO2007022123A2
(en)
|
2005-08-11 |
2007-02-22 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
|
CN102343084A
(zh)
|
2005-03-31 |
2012-02-08 |
安米林药品公司 |
用于治疗精神病和精神障碍的胰淀素和胰淀素激动剂
|
|
US20080200383A1
(en)
|
2005-04-08 |
2008-08-21 |
Amylin Pharmaceuticals, Inc. |
Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
|
|
US20090305964A1
(en)
|
2005-04-21 |
2009-12-10 |
Gastrotech Pharma A/S |
Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
|
|
US9233203B2
(en)
|
2005-05-06 |
2016-01-12 |
Medtronic Minimed, Inc. |
Medical needles for damping motion
|
|
EP1888031B1
(en)
|
2005-06-06 |
2013-01-23 |
Camurus Ab |
Glp-1 analogue formulations
|
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
WO2007013957A2
(en)
|
2005-07-22 |
2007-02-01 |
University Of Utah Research Foundation |
Osmotically driven dispense pump and related components for use in high pressure applications
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
|
PL1971362T3
(pl)
|
2005-08-19 |
2015-05-29 |
Amylin Pharmaceuticals Llc |
Eksendyna do leczenia cukrzycy i zmniejszania masy ciała
|
|
US8202837B2
(en)
|
2005-11-04 |
2012-06-19 |
Glaxosmithkline Llc |
Methods for administering hypoglycemic agents
|
|
US8039432B2
(en)
|
2005-11-09 |
2011-10-18 |
Conjuchem, Llc |
Method of treatment of diabetes and/or obesity with reduced nausea side effect
|
|
EP2364735A3
(en)
|
2005-12-16 |
2012-04-11 |
Nektar Therapeutics |
Branched PEG conjugates of GLP-1
|
|
AU2006329836A1
(en)
|
2005-12-16 |
2007-07-05 |
Amylin Pharmaceuticals, Llc |
Compositions and methods for treating obesity and related metabolic disorders
|
|
WO2007084460A2
(en)
|
2006-01-18 |
2007-07-26 |
Qps, Llc |
Pharmaceutical compositions with enhanced stability
|
|
WO2007109354A2
(en)
|
2006-03-21 |
2007-09-27 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of using same
|
|
EP2016178B1
(en)
|
2006-05-02 |
2017-07-12 |
Intrexon Actobiotics NV |
Microbial intestinal delivery of obesity related peptides
|
|
EP2029160A2
(en)
|
2006-05-12 |
2009-03-04 |
Amylin Pharmaceuticals, Inc. |
Methods to restore glycemic control
|
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
US8206735B2
(en)
|
2006-07-11 |
2012-06-26 |
Foresee Pharmaceuticals, Llc |
Pharmaceutical compositions for sustained release delivery of peptides
|
|
US8501693B2
(en)
|
2006-08-04 |
2013-08-06 |
Amylin Pharmaceuticals, Llc |
Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen
|
|
EP2359808B1
(en)
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
|
US20100098735A1
(en)
|
2006-10-05 |
2010-04-22 |
Rajesh Jain |
Injectable depot compositions and its process of preparation
|
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
|
RU2477286C2
(ru)
|
2007-01-05 |
2013-03-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
АНАЛОГИ ГЛЮКАГОНА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ В БУФЕРАХ С ФИЗИОЛОГИЧЕСКИМ ЗНАЧЕНИЕМ pH
|
|
USD555589S1
(en)
|
2007-01-23 |
2007-11-20 |
Intec, Inc. |
Battery charger and game controller cradle
|
|
WO2008092084A2
(en)
|
2007-01-26 |
2008-07-31 |
Centocor, Inc. |
Injectable non-aqueous suspension with high concentration of therapeutic agent
|
|
EP1958576A3
(en)
|
2007-02-13 |
2009-08-05 |
Arthrex Inc |
Double cut shaver
|
|
US8262667B1
(en)
|
2007-02-23 |
2012-09-11 |
Holmed Corporation |
Multi-diameter implant forceps
|
|
WO2008133908A2
(en)
|
2007-04-23 |
2008-11-06 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
WO2008134425A1
(en)
|
2007-04-27 |
2008-11-06 |
Cedars-Sinai Medical Center |
Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders
|
|
WO2009100216A1
(en)
|
2008-02-08 |
2009-08-13 |
Qps Llc |
Composition for sustained release delivery of proteins or peptides
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
AU2009214632B2
(en)
|
2008-02-14 |
2015-02-19 |
Reshape Lifesciences, Inc. |
Treatment of excess weight by neural downregulation in combination with compositions
|
|
US20110046071A1
(en)
|
2008-03-05 |
2011-02-24 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer
|
|
US20090234392A1
(en)
|
2008-03-13 |
2009-09-17 |
Depuy Spine, Inc. |
Method for inserting a spinal fixation element using implants having guide tabs
|
|
DK2268299T3
(da)
|
2008-04-01 |
2013-10-07 |
Mosamedix Bv |
Sammensætninger til reduktion af ardannelse under sårheling
|
|
US8483830B2
(en)
|
2008-04-04 |
2013-07-09 |
Enteromedics Inc. |
Methods and systems for glucose regulation
|
|
WO2009143285A2
(en)
|
2008-05-21 |
2009-11-26 |
Amylin Pharmaceuticals, Inc. |
Exendins to lower cholestrol and triglycerides
|
|
EP2303226B1
(en)
*
|
2008-06-25 |
2016-03-23 |
Endo Pharmaceuticals Solutions Inc. |
Sustained delivery of exenatide and other polypeptides
|
|
KR101814186B1
(ko)
|
2008-09-17 |
2018-03-14 |
키아스마 인코포레이티드 |
약제학적 조성물 및 연관된 투여방법
|
|
BRPI0919465A2
(pt)
|
2008-09-30 |
2015-12-01 |
Endo Pharmaceuticals Solutions |
dispositivo implantável para a liberação de risperidona e métodos de uso do mesmo
|
|
CN102281865B
(zh)
|
2008-10-15 |
2017-04-05 |
精达制药公司 |
高浓缩药物颗粒、制剂、混悬剂及其应用
|
|
EP2367503A1
(en)
|
2008-11-25 |
2011-09-28 |
AttenueX Technologies, Inc. |
Implant with high vapor pressure medium
|
|
US20100298840A1
(en)
|
2009-05-22 |
2010-11-25 |
Schwartz Lyman D |
Phimosis Treatment Device and Method
|
|
USD638478S1
(en)
|
2009-07-06 |
2011-05-24 |
Performance Designed Products Llc |
Video game controller accessory
|
|
US20110022165A1
(en)
|
2009-07-23 |
2011-01-27 |
Edwards Lifesciences Corporation |
Introducer for prosthetic heart valve
|
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
|
USD789539S1
(en)
|
2015-07-09 |
2017-06-13 |
Spinal Surgical Strategies, Llc |
Fusion cage
|
|
RU2547990C2
(ru)
|
2009-09-28 |
2015-04-10 |
Интарсия Терапьютикс, Инк. |
Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
|
|
JP6006118B2
(ja)
|
2009-12-16 |
2016-10-12 |
ノヴォ ノルディスク アー／エス |
Ｇｌｐ−１アナログ及び誘導体
|
|
AR079344A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
|
|
JO2976B1
(en)
|
2009-12-22 |
2016-03-15 |
ايلي ليلي اند كومباني |
Axentomodulin polypeptide
|
|
CN102946875A
(zh)
*
|
2010-05-05 |
2013-02-27 |
贝林格尔.英格海姆国际有限公司 |
组合疗法
|
|
WO2011156407A2
(en)
|
2010-06-09 |
2011-12-15 |
Amylin Pharmaceuticals, Inc. |
Glp-1 receptor agonists to treat pancre-atitis
|
|
USD669589S1
(en)
|
2010-08-31 |
2012-10-23 |
Koninklijke Philips Electronics N.V. |
Blood system cartridge
|
|
US8611106B2
(en)
|
2011-01-12 |
2013-12-17 |
On-Bright Electronics (Shanghai) Co., Ltd. |
Systems and methods for adjusting current consumption of control chips to reduce standby power consumption of power converters
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
WO2013004983A1
(en)
|
2011-07-04 |
2013-01-10 |
Imperial Innovations Limited |
Novel compounds and their effects on feeding behaviour
|
|
US20130098928A1
(en)
|
2011-09-16 |
2013-04-25 |
Golden Aluminum, Inc. |
Application of designs to portion of food container
|
|
TWD149032S
(zh)
|
2011-10-04 |
2012-09-01 |
虹光精密工業股份有限公司 |
手持式掃描器底座
|
|
DK2838446T3
(en)
|
2012-04-19 |
2019-01-07 |
Removaid As |
DEVICE FOR REMOVING AN OBJECT IMPLANTED UNDER THE SKIN
|
|
JP5626943B2
(ja)
|
2012-05-29 |
2014-11-19 |
国立大学法人高知大学 |
動脈可視化装置、および動脈撮像装置
|
|
US20140058425A1
(en)
|
2012-08-27 |
2014-02-27 |
Amir Porat |
Manually operated surgical devices with operative portions formed of a see-through material
|
|
US9332995B2
(en)
|
2012-09-25 |
2016-05-10 |
Russo Inventions, Llc |
Bone-harvesting tool
|
|
US9241722B2
(en)
|
2012-10-08 |
2016-01-26 |
Warsaw Orthopedic, Inc. |
Surgical pin guide and methods of use
|
|
AU2013329077A1
(en)
*
|
2012-10-11 |
2015-04-23 |
Tufts University |
Compositions and methods for sustained delivery of glucagon-like peptide (GLP-1) receptor agonist therapeutics
|
|
CN105101953A
(zh)
|
2012-11-19 |
2015-11-25 |
布雷本制药私人有限责任公司 |
可植入的药物递送组合物及其治疗方法
|
|
USD731630S1
(en)
|
2014-04-08 |
2015-06-09 |
Bootz Manufacturing Company |
Shower pan
|
|
USD724740S1
(en)
|
2014-06-05 |
2015-03-17 |
Deka Products Limited Partnership |
Enclosure for a peritoneal dialysis device
|
|
CN104258378A
(zh)
*
|
2014-09-12 |
2015-01-07 |
深圳市健元医药科技有限公司 |
一种glp-1类似物注射用缓释植入剂及其制备
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
RU2730996C2
(ru)
|
2015-06-03 |
2020-08-26 |
Интарсия Терапьютикс, Инк. |
Системы установки и извлечения имплантата
|
|
USD789540S1
(en)
|
2016-01-29 |
2017-06-13 |
Veterinary Implants Direct, Llc. |
Orthopedic plate
|
|
US9931133B2
(en)
|
2016-03-24 |
2018-04-03 |
A.M. Surgical, Inc. |
Compact endoscopic surgical device and method of use thereof
|
|
KR102574993B1
(ko)
|
2016-05-16 |
2023-09-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
JP7286542B2
(ja)
|
2017-01-03 |
2023-06-05 |
インターシア セラピューティクス，インコーポレイティド |
Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
|